Hereditary retinoblastoma patients, for example, have increased risk of subsequent unrelated cancers (Schonfeld et al., 2021), indicating that mutational inactivation of RB1 contributes to tumorigenesis in tissues beyond the retina. The gene discussed is RB1; the disease is cancer.